Loteprednol etabonate 0.5% ophthalmic suspension (Lotemax)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Loteprednol etabonate 0.5% ophthalmic suspension (Lotemax), covering 2015-09-24 to 2015-09-24. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5% [NA]